Constellation Brands reported mixed Q1 FY2027 results with revenue beating expectations but EPS missing. Despite raising full-year guidance with 23% YOY EPS growth and returning $400M to shareholders through buybacks and dividends, the stock remains near multi-year lows at $130, trading 29% below analyst targets. The beer segment showed resilience with 2% net sales growth, while wine and spirits improved significantly. Management's new occasion-based growth strategy and strong brand positioning in Modelo and Corona suggest the market hasn't fully priced in operational improvements.

PepsiCo and Molson Coors represent two different investment strategies in the consumer staples sector. PepsiCo offers stability with slow but steady growth, diversified snack and beverage brands, and a strong global presence, though it faces headwinds from GLP-1 medications and consumer spending caution. Molson Coors trades at cheaper valuations with a higher dividend yield but struggles with declining beer sales and is in the midst of a risky turnaround into premium beverages. The article recommends PepsiCo as the safer choice despite Molson Coors' attractive valuation metrics.

The article compares Diageo and Brown-Forman as investment options in the struggling spirits industry. Both stocks have fallen significantly over five years due to declining alcohol consumption among U.S. adults, particularly younger generations. While Brown-Forman shows stronger profitability margins (21.9%) and financial health, Diageo offers greater global diversification. The analyst recommends waiting for improved earnings results before buying either stock, but favors Diageo long-term due to its international exposure and acquisition potential.

Under new CEO Greg Abel, Berkshire Hathaway halted its multi-quarter Apple selling trend and more than tripled its Alphabet stake in Q1 2026, signaling a shift toward technology investments. Apple reported strong fundamentals with 17% revenue growth and 22% EPS growth, though rising memory costs present a near-term risk.

Diageo, the world's largest spirits producer, has seen its stock decline nearly 30% over the past year and 50% over five years due to declining U.S. spirits sales, Asian market weakness, and oversupply in the tequila market. The company cut its dividend by 80% and expects organic net sales to decline 2-3% in fiscal 2026. While the stock trades at a cheap 12x forward earnings, the analyst expects it to stagnate or decline further over the next 12 months as the company works through structural challenges.

Brown-Forman (BFb) is at the center of acquisition interest with Sazerac offering $15 billion in cash ($32/share) and Pernod Ricard also reportedly interested. The stock has surged 25% in 30 days, trading at ~$29/share on merger premium expectations. The Brown family's dual-class voting control will likely determine the outcome, with potential preference for Pernod Ricard's strategic distribution network over Sazerac's cash offer. The article contrasts this with Constellation Brands' organic growth success.

Sazerac has made a $15 billion acquisition proposal for Brown-Forman at $32 per share, potentially disrupting ongoing merger discussions with Pernod Ricard. The competing bids reflect industry consolidation driven by declining U.S. alcohol consumption due to health trends and GLP-1 drugs. A Pernod merger would offer stronger growth prospects in emerging markets, while Sazerac's advantage lies in its Louisville bourbon industry ties and distributor relationships.

Q1 2026 earnings season kicks off with strong results from major banks. The S&P 500 is projected to deliver 12.6% EPS growth for the sixth consecutive quarter, driven by a 45% surge in Information Technology. However, companies like Constellation Brands are withdrawing forward guidance due to geopolitical uncertainties and volatile energy costs, signaling a cautious outlook for the second half of 2026.

U.S. stock futures declined on Thursday following geopolitical tensions as Iran accused Washington of ceasefire violations. The S&P 500, Dow Jones, and Nasdaq 100 futures all fell slightly. Major economic data releases are expected, and the Fed is expected to hold rates steady at its April meeting. Several stocks moved significantly on earnings and strategic announcements.

Constellation Brands beat Q4 earnings expectations with $1.90 EPS versus $1.71 consensus and $1.92B revenue versus $1.86B estimate. However, the stock fell 2% to $147.26 after the company issued a disappointing fiscal 2027 outlook, guiding for adjusted EPS of $11.20-$11.90 versus the $12.37 analyst estimate.

Delta Air Lines faces headwinds from rising jet fuel and diesel prices despite expected 5.4% sales growth and 34.3% earnings growth, with analysts cutting estimates. Constellation Brands struggles with declining beer consumption and weak wine market, forecasting 13.3% sales decline and 35.1% earnings fall.

Oil prices surged 90% year-to-date amid U.S.-Iran tensions and Trump's Strait of Hormuz deadline, pushing gasoline above $4/gallon and raising inflation concerns. Markets await Friday's March CPI and Thursday's PCE data as key inflation tests. The S&P 500 snapped a five-week losing streak with a 3%+ gain, though it remains 6% below January records. Delta Air Lines reports Q1 earnings with mixed airline sector outlook.